Unicorn Finder Launchpad Boost Startup 2021
Unicorn Finder Launchpad Model
We surround you with a dense network of partners – from hospitals to world-leading research institutes, from regulation, reimbursement and intellectual property experts to multinational corporations, from product development firms to investors and more.
Supported by the Incheon Metropolitan City and the Central Government (Ministry of SMEs, Ministry of Science and ICT, etc.)
Platform for Technological Innovation and Growth of SMEs and Startups
Ministry of SMEs and Startups, Business Start-up Promotion Agency, Incheon City, Incheon Free Economic Zone Authority, Incheon Techno Park
The Korean version of Silicon Valley
Early stage VC and Top Startup Accelerator in Korea
Top cross-border accelerator across Asia
Expanding to Southeast Asia
Well-funded, product ready startups in Korea, targeting to SEA through Singapore
Pre series A
A smartphone is an important tool for everyone to communicate, get information, work, and play in everyday life.
Rivo is an assistive technology product for the blind and visually impaired to use the smartphone more freely. It connects and works as if it were the same smartphone.
Pre Series A
Propwave has focused on developing two items: mozip to visualize and predict the direction and price volatility of residential real estate, and mozip now to provide time-based real estate sublet services based on data accumulated in the process.
Liquid Handling Robot
Pre series A
Our company aspires to create new value by developing innovative medical devices based on advanced robotic technology to enhance human life quality.
Gait Training Robot – ADVANCE
Complex Upper & Lower Limb Rehabilitation Robot System
Gait Training Robot – PRO
Gait Rehabilitation Robot System
Gait Training Robot – STANDARD
Entry-Level Gait Rehabilitation Robot System
Pre Series A
Hedgehog, Inc., aiming to maximize the anticancer efficacy by minimizing side effects of the existing anticancer drugs and effectively suppressing hedgehog signaling, we develop new antibodies and small-molecule compound drugs to overcome drug tolerance and secure safety.
Thus, we develop anticancer drugs to secure peerless original technology and preoccupy the market.
Development of First-in-class / Best-in-class antibody and synthetic new drugs for treating solid cancer
According to the planned roadmap, we carry out phased development of new antibodies and synthetic new drugs with effective power of inhibiting hedgehog signaling to treat solid cancer.